Pharmatrophix
Raleigh, US · Delaware corporation · 1 known investors
Founders & leadership
FM
Frank M. LongoFounder
AC
Anne C. LongoExecutive
Board
RS
Robert SimsBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.3M disclosed across 1 round · 2014
▶$10.3MraisedNov 2015 · 15 investors · PharmaceuticalsRule 506(b)
▶$10.3MraisedNov 2015 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anne C. LongoExecutive Officer
- Robert SimsDirector
- Frank M. LongoDirector
- Offering amount
- $10.3M
- Amount sold
- $10.3M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapBioworld15 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
ADvantage Therapeutics7 shared keywords
Companies competing with Pharmatrophix for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who founded Pharmatrophix?
- Pharmatrophix was founded by Frank M. Longo.
- Who are Pharmatrophix's investors?
- Pharmatrophix's investors include Dolby Family Ventures.
- How much funding has Pharmatrophix raised?
- Pharmatrophix has disclosed $10.3M raised across 1 round.
- Where is Pharmatrophix headquartered?
- Pharmatrophix is headquartered in Raleigh, US.